Table of contents
Volume 92, Issue 6
Published online 22 March 2005 (985-1177)
Clinical Studies |
Translational Therapeutics |
Molecular Diagnostics |
Genetics and Genomics |
Letters to the Editor |
Book Review
Minireview
SNAIL vs vitamin D receptor expression in colon cancer: therapeutics implications FREE
M J Larriba and A Muñoz
Br J Cancer 92: 985-989; advance online publication, March 15, 2005; doi:10.1038/sj.bjc.6602484
Clinical Studies
The psychological impact of human papillomavirus testing in women with borderline or mildly dyskaryotic cervical smear test results: 6-month follow-up FREE
E Maissi, T M Marteau, M Hankins, S Moss, R Legood and A Gray
Br J Cancer 92: 990-994; doi:10.1038/sj.bjc.6602411
Suicides among Danish cancer patients 1971–1999 FREE
U Yousaf, M-LM Christensen, G Engholm and H H Storm
Br J Cancer 92: 995-1000; advance online publication, March 1, 2005; doi:10.1038/sj.bjc.6602424
Patient motivations surrounding participation in phase I and phase II clinical trials of cancer chemotherapy FREE
Z A Nurgat, W Craig, N C Campbell, J D Bissett, J Cassidy and M C Nicolson
Br J Cancer 92: 1001-1005; advance online publication, March 15, 2005; doi:10.1038/sj.bjc.6602423
Phase I study of temozolomide plus paclitaxel in patients with advanced malignant melanoma and associated in vitro investigations FREE
A Azzabi, A N Hughes, P M Calvert, E R Plummer, R Todd, M J Griffin, M J Lind, A Maraveyas, C Kelly, K Fishwick, A H Calvert and A V Boddy
Br J Cancer 92: 1006-1012; advance online publication, March 8, 2005; doi:10.1038/sj.bjc.6602438
Phase II study of weekly vinorelbine and 24-h infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancer FREE
K H Yeh, Y S Lu, C H Hsu, J F Lin, H J Chao, T C Huang, C Y Chung, C S Chang, C H Yang and A L Cheng
Br J Cancer 92: 1013-1018; advance online publication, March 15, 2005; doi:10.1038/sj.bjc.6602469
Phase I/II study of oral etoposide plus GM-CSF as second-line chemotherapy in platinum-pretreated patients with advanced ovarian cancer FREE
M Baur, E Schernhammer, M Gneist, P Sevelda, P Speiser, M Hudec and Ch Dittrich
Br J Cancer 92: 1019-1025; advance online publication, March 8, 2005; doi:10.1038/sj.bjc.6602427
Secondary cytoreductive surgery for recurrent epithelial ovarian carcinoma: proposal for patients selection FREE
T Onda, H Yoshikawa, T Yasugi, M Yamada, K Matsumoto and Y Taketani
Br J Cancer 92: 1026-1032; advance online publication, March 15, 2005; doi:10.1038/sj.bjc.6602466
Survival following lobectomy vs limited resection for stage I lung cancer: a meta-analysis FREE
H Nakamura, N Kawasaki, M Taguchi and K Kabasawa
Br J Cancer 92: 1033-1037; advance online publication, March 8, 2005; doi:10.1038/sj.bjc.6602414
A prospective, randomised study to compare two palliative radiotherapy schedules for non-small-cell lung cancer (NSCLC) FREE
E Senkus-Konefka, R Dziadziuszko, E Bednaruk-M
y
ski, A Pliszka, J Kubrak, A Lewandowska, K Maachowski, M Wierzchowski, M Matecka-Nowak and J Jassem
Br J Cancer 92: 1038-1045; advance online publication, March 15, 2005; doi:10.1038/sj.bjc.6602477
Impact of combined 18F-FDG PET/CT in head and neck tumours FREE
R Syed, J B Bomanji, N Nagabhushan, S Hughes, I Kayani, A Groves, S Gacinovic, N Hydes, D Visvikis, C Copland and P J Ell
Br J Cancer 92: 1046-1050; advance online publication, March 15, 2005; doi:10.1038/sj.bjc.6602464
Over-D1 dissection may question the value of radiotherapy as a part of an adjuvant programme in high-risk radically resected gastric cancer patients FREE
M Scartozzi, E Galizia, F Graziano, V Catalano, R Berardi, A M Baldelli, E Testa, D Mari, R R Silva and S Cascinu
Br J Cancer 92: 1051-1054; advance online publication, March 15, 2005; doi:10.1038/sj.bjc.6602468
Optimisation of irinotecan dose in the treatment of patients with metastatic colorectal cancer after 5-FU failure: results from a multinational, randomised phase II study FREE
E Van Cutsem, L Dirix, J-L Van Laethem, S Van Belle, M Borner, M Gonzalez Baron, A Roth, R Morant, E Joosens, G Gruia, D Sibaud and H Bleiberg
Br J Cancer 92: 1055-1062; advance online publication, March 8, 2005; doi:10.1038/sj.bjc.6602462
Translational Therapeutics
Epidermal growth factor receptor double targeting by a tyrosine kinase inhibitor (Iressa) and a monoclonal antibody (Cetuximab). Impact on cell growth and molecular factors FREE
J-L Fischel, P Formento and G Milano
Br J Cancer 92: 1063-1068; advance online publication, March 8, 2005; doi:10.1038/sj.bjc.6602428
Engineering and characterisation of chimeric monoclonal antibody 806 (ch806) for targeted immunotherapy of tumours expressing de2-7 EGFR or amplified EGFR FREE
C Panousis, V M Rayzman, T G Johns, C Renner, Z Liu, G Cartwright, F-T Lee, D Wang, H Gan, D Cao, A Kypridis, F E Smyth, M W Brechbiel, A W Burgess, L J Old and A M Scott
Br J Cancer 92: 1069-1077; advance online publication, March 15, 2005; doi:10.1038/sj.bjc.6602470
MET signalling in primary colon epithelial cells leads to increased transformation irrespective of aberrant Wnt signalling FREE
E M J Boon, M Kovarikova, P W B Derksen and R van der Neut
Br J Cancer 92: 1078-1083; doi:10.1038/sj.bjc.6602405
Molecular Diagnostics
Dexamethasone-induced cisplatin and gemcitabine resistance in lung carcinoma samples treated ex vivo FREE
N Gassler, C Zhang, T Wenger, P A Schnabel, H Dienemann, K-M Debatin, J Mattern and I Herr
Br J Cancer 92: 1084-1088; advance online publication, March 8, 2005; doi:10.1038/sj.bjc.6602453
Targeting of Rad51-dependent homologous recombination: implications for the radiation sensitivity of human lung cancer cell lines FREE
A Sak, G Stueben, M Groneberg, W Böcker and M Stuschke
Br J Cancer 92: 1089-1097; doi:10.1038/sj.bjc.6602457
K-ras mutation in the endometrium of tamoxifen-treated breast cancer patients, with a comparison of tamoxifen and toremifene FREE
T Hachisuga, H Tsujioka, S Horiuchi, T Udou, M Emoto and T Kawarabayashi
Br J Cancer 92: 1098-1103; advance online publication, March 8, 2005; doi:10.1038/sj.bjc.6602456
Long-term morphological and hormonal follow-up in a single unit on 115 patients with adrenal incidentalomas FREE
G P Bernini, A Moretti, C Oriandini, M Bardini, C Taurino and A Salvetti
Br J Cancer 92: 1104-1109; advance online publication, March 15, 2005; doi:10.1038/sj.bjc.6602459
Efficacy of epidermal growth factor receptor-targeted molecular therapy in anaplastic thyroid cancer cell lines FREE
Y Nobuhara, N Onoda, Y Yamashita, M Yamasaki, K Ogisawa, T Takashima, T Ishikawa and K Hirakawa
Br J Cancer 92: 1110-1116; doi:10.1038/sj.bjc.6602461
Aberrant promoter methylation in human DAB2 interactive protein (hDAB2IP) gene in gastrointestinal tumour FREE
H Dote, S Toyooka, K Tsukuda, M Yano, T Ota, M Murakami, M Naito, M Toyota, A F Gazdar and N Shimizu
Br J Cancer 92: 1117-1125; advance online publication, March 15, 2005; doi:10.1038/sj.bjc.6602458
Genetics and Genomics
Mutation analysis of three genes encoding novel LKB1-interacting proteins, BRG1, STRAD
, and MO25, in Peutz–Jeghers syndrome FREE
P Alhopuro, P Katajisto, R Lehtonen, S K Ylisaukko-oja, L Näätsaari, A Karhu, A M Westerman, J H P Wilson, F W M de Rooij, T Vogel, G Moeslein, I P Tomlinson, L A Aaltonen, T P Mäkelä and V Launonen
Br J Cancer 92: 1126-1129; advance online publication, March 8, 2005; doi:10.1038/sj.bjc.6602454
Gene expression profiles in human gastric cancer: expression of maspin correlates with lymph node metastasis FREE
M Terashima, C Maesawa, K Oyama, S Ohtani, Y Akiyama, S Ogasawara, A Takagane, K Saito, T Masuda, N Kanzaki, S Matsuyama, Y Hoshino, M Kogure, M Gotoh, M Shirane and K Mori
Br J Cancer 92: 1130-1136; advance online publication, March 15, 2005; doi:10.1038/sj.bjc.6602429
Aspirin-induced nuclear translocation of NF
B and apoptosis in colorectal cancer is independent of p53 status and DNA mismatch repair proficiency FREE
F V N Din, L A Stark and M G Dunlop
Br J Cancer 92: 1137-1143; advance online publication, March 15, 2005; doi:10.1038/sj.bjc.6602455
The R72P P53 mutation is associated with familial breast cancer in Jewish women FREE
T Ohayon, R Gershoni-Baruch, M Z Papa, T Distelman Menachem, S Eisenberg Barzilai and E Friedman
Br J Cancer 92: 1144-1148; advance online publication, March 1, 2005; doi:10.1038/sj.bjc.6602451
Identification of genes associated with platinum drug sensitivity and resistance in human ovarian cancer cells FREE
D Roberts, J Schick, S Conway, S Biade, P B Laub, J P Stevenson, T C Hamilton, P J O'Dwyer and S W Johnson
Br J Cancer 92: 1149-1158; advance online publication, February 22, 2005; doi:10.1038/sj.bjc.6602447
Mutation screening and association study of RNASEL as a prostate cancer susceptibility gene FREE
C Maier, J Haeusler, K Herkommer, Z Vesovic, J Hoegel, W Vogel and T Paiss
Br J Cancer 92: 1159-1164; advance online publication, February 15, 2005; doi:10.1038/sj.bjc.6602401
Aberrant DNA methylation associated with silencing BNIP3 gene expression in haematopoietic tumours FREE
M Murai, M Toyota, A Satoh, H Suzuki, K Akino, H Mita, Y Sasaki, T Ishida, L Shen, G Garcia-Manero, J-P J Issa, Y Hinoda, T Tokino and K Imai
Br J Cancer 92: 1165-1172; advance online publication, March 8, 2005; doi:10.1038/sj.bjc.6602422
Letters to the Editor
Aromatase inhibitors in advanced breast cancer: there are efficacy differences FREE
A S Bhatnagar
Br J Cancer 92: 1173-1174; advance online publication, March 15, 2005; doi:10.1038/sj.bjc.6602434
Reply: aromatase inhibition in advanced breast cancer: no conclusive evidence of efficacy differences FREE
R Sainsbury
Br J Cancer 92: 1175-1176; advance online publication, March 15, 2005; doi:10.1038/sj.bjc.6602435
Book Review
Principles of Molecular Pathology FREE
K Stoeber
Br J Cancer 92: 1177; doi:10.1038/sj.bjc.6602482
The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.
